Lifetime cost-effectiveness of rosiglitazone/metformin fixed dose combination for the treatment of type 2 diabetes in Portugal

被引：0

|

作者：

Taylor, M.

Shearer, A.

Bagust, A.

Vaz, J. P.

Pereira, J.

机构：

来源：

DIABETES | 2006年 / 55卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：A548 / A548

页数：1

相关论文

共 50 条

[11] Cost-effectiveness of rosiglitazone for treatment of type 2 diabetes in Portugal using different methods to model clinical
Taylor, M. J.
Bagust, A.
Pereira, J. A.
Mendes da Costa, S.
Beale, S.
Shearer, A.
VALUE IN HEALTH, 2006, 9 (06) : A232 - A232
[12] Initial treatment with rosiglitazone/metformin fixed-dose combination therapy compared with monotherapy with either rosiglitazone or metformin in patients with uncontrolled type 2 diabetes
Rosenstock, J.
Rood, J.
Cobitz, A.
Biswas, N.
Chou, H.
Garber, A.
DIABETES OBESITY & METABOLISM, 2006, 8 (06): : 650 - 660
[13] Cost-effectiveness of metformin plus vildagliptin versus metformin plus sulphonylurea for the treatment of type 2 diabetes patients in Portugal
Viriato, D.
Calado, F.
Gruenberger, J-B.
Ong, S. H.
Carvalho, D.
Silva-Nunes, J.
Johal, S.
Viana, R.
DIABETOLOGIA, 2014, 57 : S328 - S328
[14] Cost-effectiveness of liraglutide versus rosiglitazone, both in combination with glimepiride in treatment of type 2 diabetes in the US
Lee, W. C.
Conner, C.
Hammer, M.
CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (05) : 897 - 906
[15] Rosiglitazone Maleate and Metformin Hydrochloride in Fixed combination: What Role in the Treatment of Type 2 Diabetes?
Farah, Raymond
CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 : 1215 - 1225
[16] Fixed-dose combination of sitagliptin and metformin for the treatment of type 2 diabetes
Reynolds, Jonathan K.
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2009, 2 : 127 - 134
[17] The cost-effectiveness of adding rosiglitazone versus sulfonlurea to metformin in a US obese type 2 diabetes population
Richter, A
Thieda, P
Bagust, A
Perry, A
DIABETES, 2003, 52 : A524 - A524
[18] Response to Pokharna and Kanna: Initial treatment with rosiglitazone/metformin fixed-dose combination therapy compared with monotherapy with either rosiglitazone or metformin in patients with uncontrolled type 2 diabetes
Garber, A.
DIABETES OBESITY & METABOLISM, 2008, 10 (05): : 436 - 437
[19] Spotlight on the Low dose Rosiglitazone/ Metformin Combination In Prevention of Type 2 Diabetes
Hadi, Muhammad Abdul
ARCHIVES OF PHARMACY PRACTICE, 2010, 1 (01) : 2 - 2
[20] Fixed-Dose Combination of Canagliflozin and Metformin for the Treatment of Type 2 Diabetes: An Overview
Davidson, Jaime A.
Sloan, Lance
ADVANCES IN THERAPY, 2017, 34 (01) : 41 - 59

← 1 2 3 4 5 →